Treatment plan: Once approved, well create a personalized treatment program where youll learn about potential side effects and receive tailored recommendations for lifestyle and dietary changes to help maximize your results
It contains Tranexamic acid (1,000ppm) that is is known for its ability to lighten and brighten the skin, making it the perfect ingredient to combat dark circles and hyperpigmentation
Indeed, CDER Acting Director Michael Davis reinforced the policy point publicly on X, emphasizing that compounded GLP1 products are not FDAapproved and have not undergone the rigorous review for safety, efficacy, and manufacturing quality that is required for drugs approved through the new drug application (NDA) or abbreviated new drug application (ANDA) pathways.[3] This is now the third major set of warning letters in less than a year with the majority aimed at telehealth marketing of compounded GLP-1 products: September 2025: roughly 80 warning letters and 40 untitled letters March 2026: 30 warning letters June 2026: 25 warning letters The Claims FDA Is Targeting As in earlier rounds, the June 2026 letters appear highly standardized and focus on consumerfacing promotion of compounded GLP-1 products
Differences in peptide purity, identity, or manufacturing consistency can affect experimental reproducibility
The FDA has updated its stance on compounding, with the semaglutide shortage now resolved
189 ZhangE.ShotboltM.ChangC.Scott-VandeusenA.ChenS.LiangP.et al (2024)
